ID   MKS3_HUMAN              Reviewed;         995 AA.
AC   Q5HYA8; B3KRU5; B3KT47; G5E9H2; Q3ZCX3; Q7Z5T8; Q8IZ06;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   28-JAN-2026, entry version 179.
DE   RecName: Full=Meckelin;
DE   AltName: Full=Meckel syndrome type 3 protein;
DE   AltName: Full=Transmembrane protein 67;
DE   Flags: Precursor;
GN   Name=TMEM67; Synonyms=MKS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-604.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-995, AND VARIANT VAL-604.
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-995.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT MKS3
RP   PRO-376, FUNCTION, AND INTERACTION WITH MKS1.
RX   PubMed=17185389; DOI=10.1093/hmg/ddl459;
RA   Dawe H.R., Smith U.M., Cullinane A.R., Gerrelli D., Cox P., Badano J.L.,
RA   Blair-Reid S., Sriram N., Katsanis N., Attie-Bitach T., Afford S.C.,
RA   Copp A.J., Kelly D.A., Gull K., Johnson C.A.;
RT   "The Meckel-Gruber syndrome proteins MKS1 and meckelin interact and are
RT   required for primary cilium formation.";
RL   Hum. Mol. Genet. 16:173-186(2007).
RN   [7]
RP   FUNCTION.
RX   PubMed=19515853; DOI=10.1093/hmg/ddp272;
RA   Tammachote R., Hommerding C.J., Sinders R.M., Miller C.A., Czarnecki P.G.,
RA   Leightner A.C., Salisbury J.L., Ward C.J., Torres V.E., Gattone V.H. II,
RA   Harris P.C.;
RT   "Ciliary and centrosomal defects associated with mutation and depletion of
RT   the Meckel syndrome genes MKS1 and MKS3.";
RL   Hum. Mol. Genet. 18:3311-3323(2009).
RN   [8]
RP   SUBCELLULAR LOCATION, TOPOLOGY, FUNCTION, AND INTERACTION WITH DNAJB9;
RP   DNAJC10 AND SFTPC.
RX   PubMed=19815549; DOI=10.1074/jbc.m109.034371;
RA   Wang M., Bridges J.P., Na C.L., Xu Y., Weaver T.E.;
RT   "Meckel-Gruber syndrome protein MKS3 is required for endoplasmic reticulum-
RT   associated degradation of surfactant protein C.";
RL   J. Biol. Chem. 284:33377-33383(2009).
RN   [9]
RP   SUBCELLULAR LOCATION, INTERACTION WITH SYNE2, AND FUNCTION.
RX   PubMed=19596800; DOI=10.1242/jcs.043794;
RA   Dawe H.R., Adams M., Wheway G., Szymanska K., Logan C.V., Noegel A.A.,
RA   Gull K., Johnson C.A.;
RT   "Nesprin-2 interacts with meckelin and mediates ciliogenesis via
RT   remodelling of the actin cytoskeleton.";
RL   J. Cell Sci. 122:2716-2726(2009).
RN   [10]
RP   INTERACTION WITH FLNA, AND SUBCELLULAR LOCATION.
RX   PubMed=22121117; DOI=10.1093/hmg/ddr557;
RA   Adams M., Simms R.J., Abdelhamed Z., Dawe H.R., Szymanska K., Logan C.V.,
RA   Wheway G., Pitt E., Gull K., Knowles M.A., Blair E., Cross S.H.,
RA   Sayer J.A., Johnson C.A.;
RT   "A meckelin-filamin A interaction mediates ciliogenesis.";
RL   Hum. Mol. Genet. 21:1272-1286(2012).
RN   [11]
RP   INTERACTION WITH TMEM218.
RX   PubMed=35137054; DOI=10.1093/hmg/ddac027;
RA   Epting D., Decker E., Ott E., Eisenberger T., Bader I., Bachmann N.,
RA   Bergmann C.;
RT   "The ciliary transition zone protein TMEM218 synergistically interacts with
RT   the NPHP module and its reduced dosage leads to a wide range of syndromic
RT   ciliopathies.";
RL   Hum. Mol. Genet. 0:0-0(2022).
RN   [12]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.34 ANGSTROMS), TOPOLOGY, REGION, COILED
RP   COIL, DISULFIDE BONDS, SUBUNIT, GLYCOSYLATION AT ASN-141; ASN-179; ASN-242
RP   AND ASN-318, AND INTERACTION WITH WNT5A.
RX   PubMed=34731008; DOI=10.1126/sciadv.abj9748;
RA   Liu D., Qian D., Shen H., Gong D.;
RT   "Structure of the human Meckel-Gruber protein Meckelin.";
RL   Sci. Adv. 7:eabj9748-eabj9748(2021).
RN   [13]
RP   VARIANT MKS3 PRO-376, AND TISSUE SPECIFICITY.
RX   PubMed=16415887; DOI=10.1038/ng1713;
RA   Smith U.M., Consugar M., Tee L.J., McKee B.M., Maina E.N., Whelan S.,
RA   Morgan N.V., Goranson E., Gissen P., Lilliquist S., Aligianis I.A.,
RA   Ward C.J., Pasha S., Punyashthiti R., Malik Sharif S., Batman P.A.,
RA   Bennett C.P., Woods C.G., McKeown C., Bucourt M., Miller C.A., Cox P.,
RA   Algazali L., Trembath R.C., Torres V.E., Attie-Bitach T., Kelly D.A.,
RA   Maher E.R., Gattone V.H., Harris P.C., Johnson C.A.;
RT   "The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber
RT   syndrome and the wpk rat.";
RL   Nat. Genet. 38:191-196(2006).
RN   [14]
RP   VARIANTS JBTS6 CYS-513 AND GLU-545.
RX   PubMed=17160906; DOI=10.1086/510499;
RA   Baala L., Romano S., Khaddour R., Saunier S., Smith U.M., Audollent S.,
RA   Ozilou C., Faivre L., Laurent N., Foliguet B., Munnich A., Lyonnet S.,
RA   Salomon R., Encha-Razavi F., Gubler M.-C., Boddaert N., de Lonlay P.,
RA   Johnson C.A., Vekemans M., Antignac C., Attie-Bitach T.;
RT   "The Meckel-Gruber syndrome gene, MKS3, is mutated in Joubert syndrome.";
RL   Am. J. Hum. Genet. 80:186-194(2007).
RN   [15]
RP   VARIANTS MKS3 208-ARG--ILE-995 DEL; THR-252; GLN-440; 451-ARG--ILE-995 DEL
RP   AND PRO-966.
RX   PubMed=17377820; DOI=10.1007/s00439-007-0341-3;
RA   Consugar M.B., Kubly V.J., Lager D.J., Hommerding C.J., Wong W.C.,
RA   Bakker E., Gattone V.H. II, Torres V.E., Breuning M.H., Harris P.C.;
RT   "Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic
RT   differences between MKS1 and MKS3.";
RL   Hum. Genet. 121:591-599(2007).
RN   [16]
RP   VARIANTS ALA-218; ASN-261; CYS-320 AND VAL-437, AND INVOLVEMENT IN BBS14.
RX   PubMed=18327255; DOI=10.1038/ng.97;
RA   Leitch C.C., Zaghloul N.A., Davis E.E., Stoetzel C., Diaz-Font A., Rix S.,
RA   Alfadhel M., Lewis R.A., Eyaid W., Banin E., Dollfus H., Beales P.L.,
RA   Badano J.L., Katsanis N.;
RT   "Hypomorphic mutations in syndromic encephalocele genes are associated with
RT   Bardet-Biedl syndrome.";
RL   Nat. Genet. 40:443-448(2008).
RN   [17]
RP   ERRATUM OF PUBMED:18327255.
RA   Leitch C.C., Zaghloul N.A., Davis E.E., Stoetzel C., Diaz-Font A., Rix S.,
RA   Alfadhel M., Lewis R.A., Eyaid W., Banin E., Dollfus H., Beales P.L.,
RA   Badano J.L., Katsanis N.;
RL   Nat. Genet. 40:927-927(2008).
RN   [18]
RP   VARIANTS COACH1 ARG-130; LYS-372; GLN-440; SER-590; GLY-728; ARG-782;
RP   SER-820 AND THR-833.
RX   PubMed=19058225; DOI=10.1002/humu.20924;
RA   Brancati F., Iannicelli M., Travaglini L., Mazzotta A., Bertini E.,
RA   Boltshauser E., D'Arrigo S., Emma F., Fazzi E., Gallizzi R., Gentile M.,
RA   Loncarevic D., Mejaski-Bosnjak V., Pantaleoni C., Rigoli L.,
RA   Salpietro C.D., Signorini S., Stringini G.R., Verloes A., Zabloka D.,
RA   Dallapiccola B., Gleeson J.G., Valente E.M.;
RT   "MKS3/TMEM67 mutations are a major cause of COACH Syndrome, a Joubert
RT   Syndrome related disorder with liver involvement.";
RL   Hum. Mutat. 30:E432-E442(2009).
RN   [19]
RP   VARIANTS MKS3 CYS-54; PHE-245; THR-252; CYS-296; GLN-440; CYS-513; ARG-615
RP   AND PRO-966.
RX   PubMed=19466712; DOI=10.1002/humu.21057;
RA   Tallila J., Salonen R., Kohlschmidt N., Peltonen L., Kestilae M.;
RT   "Mutation spectrum of Meckel syndrome genes: one group of syndromes or
RT   several distinct groups?";
RL   Hum. Mutat. 30:E813-E830(2009).
RN   [20]
RP   VARIANTS NPHP11 LEU-290; ARG-615; SER-821 AND ARG-821, AND VARIANTS JBTS6
RP   44-GLN--ILE-995 DEL; 208-ARG--ILE-995 DEL; THR-252; ARG-615; ARG-821 AND
RP   THR-833.
RX   PubMed=19508969; DOI=10.1136/jmg.2009.066613;
RA   Otto E.A., Tory K., Attanasio M., Zhou W., Chaki M., Paruchuri Y.,
RA   Wise E.L., Wolf M.T.F., Utsch B., Becker C., Nuernberg G., Nuernberg P.,
RA   Nayir A., Saunier S., Antignac C., Hildebrandt F.;
RT   "Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis
RT   with liver fibrosis (NPHP11).";
RL   J. Med. Genet. 46:663-670(2009).
RN   [21]
RP   VARIANTS LYS-90; LYS-124; GLU-301; ASP-569; VAL-616 AND ARG-739, AND
RP   VARIANTS MKS3 SER-349; LEU-441; ARG-668; GLU-786 AND CYS-843.
RX   PubMed=20232449; DOI=10.1002/humu.21239;
RG   International JSRD Study Group;
RA   Iannicelli M., Brancati F., Mougou-Zerelli S., Mazzotta A., Thomas S.,
RA   Elkhartoufi N., Travaglini L., Gomes C., Ardissino G.L., Bertini E.,
RA   Boltshauser E., Castorina P., D'Arrigo S., Fischetto R., Leroy B.,
RA   Loget P., Bonniere M., Starck L., Tantau J., Gentilin B., Majore S.,
RA   Swistun D., Flori E., Lalatta F., Pantaleoni C., Penzien J., Grammatico P.,
RA   Dallapiccola B., Gleeson J.G., Attie-Bitach T., Valente E.M.;
RT   "Novel TMEM67 mutations and genotype-phenotype correlates in meckelin-
RT   related ciliopathies.";
RL   Hum. Mutat. 31:E1319-E1331(2010).
RN   [22]
RP   VARIANTS COACH1 ASN-99; ARG-130; GLN-172; SER-242; THR-252; VAL-257;
RP   SER-349; LEU-358; LYS-372; GLU-376; CYS-441; SER-485; CYS-513; ARG-615;
RP   LEU-637; THR-833; PRO-841 AND CYS-942, AND VARIANTS JBTS6 ARG-82 AND
RP   SER-82.
RX   PubMed=19574260; DOI=10.1136/jmg.2009.067249;
RA   Doherty D., Parisi M.A., Finn L.S., Gunay-Aygun M., Al-Mateen M., Bates D.,
RA   Clericuzio C., Demir H., Dorschner M., van Essen A.J., Gahl W.A.,
RA   Gentile M., Gorden N.T., Hikida A., Knutzen D., Ozyurek H., Phelps I.,
RA   Rosenthal P., Verloes A., Weigand H., Chance P.F., Dobyns W.B., Glass I.A.;
RT   "Mutations in 3 genes (MKS3, CC2D2A and RPGRIP1L) cause COACH syndrome
RT   (Joubert syndrome with congenital hepatic fibrosis).";
RL   J. Med. Genet. 47:8-21(2010).
RN   [23]
RP   VARIANTS JBTS6 LEU-358 AND THR-833.
RX   PubMed=21633164; DOI=10.1172/jci43639;
RA   Dafinger C., Liebau M.C., Elsayed S.M., Hellenbroich Y., Boltshauser E.,
RA   Korenke G.C., Fabretti F., Janecke A.R., Ebermann I., Nurnberg G.,
RA   Nurnberg P., Zentgraf H., Koerber F., Addicks K., Elsobky E., Benzing T.,
RA   Schermer B., Bolz H.J.;
RT   "Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and
RT   microtubule dynamics.";
RL   J. Clin. Invest. 121:2662-2667(2011).
RN   [24]
RP   VARIANT JBTS6 ALA-711.
RX   PubMed=26477546; DOI=10.1016/j.ajhg.2015.09.009;
RG   Care4Rare Canada Consortium;
RA   Srour M., Hamdan F.F., McKnight D., Davis E., Mandel H.,
RA   Schwartzentruber J., Martin B., Patry L., Nassif C., Dionne-Laporte A.,
RA   Ospina L.H., Lemyre E., Massicotte C., Laframboise R., Maranda B.,
RA   Labuda D., Decarie J.C., Rypens F., Goldsher D., Fallet-Bianco C.,
RA   Soucy J.F., Laberge A.M., Maftei C., Boycott K., Brais B., Boucher R.M.,
RA   Rouleau G.A., Katsanis N., Majewski J., Elpeleg O., Kukolich M.K.,
RA   Shalev S., Michaud J.L.;
RT   "Joubert Syndrome in French Canadians and Identification of Mutations in
RT   CEP104.";
RL   Am. J. Hum. Genet. 97:744-753(2015).
RN   [25]
RP   CHARACTERIZATION OF VARIANTS MKS3 THR-252; SER-349; PRO-376; GLN-440;
RP   CYS-549 AND ARG-615, INTERACTION WITH WNT5A AND ROR2, AND FUNCTION.
RX   PubMed=26035863; DOI=10.1242/dmm.019083;
RA   Abdelhamed Z.A., Natarajan S., Wheway G., Inglehearn C.F., Toomes C.,
RA   Johnson C.A., Jagger D.J.;
RT   "The Meckel-Gruber syndrome protein TMEM67 controls basal body positioning
RT   and epithelial branching morphogenesis in mice via the non-canonical Wnt
RT   pathway.";
RL   Dis. Model. Mech. 8:527-541(2015).
RN   [26]
RP   VARIANT MKS3 CYS-549.
RX   PubMed=26191240;
RA   Zhang M., Cheng J., Liu A., Wang L., Xiong L., Chen M., Sun Y., Li J.,
RA   Lu Y., Yuan H., Li Y., Lu Y.;
RT   "A missense mutation in TMEM67 causes Meckel-Gruber syndrome type 3 (MKS3):
RT   a family from China.";
RL   Int. J. Clin. Exp. Pathol. 8:5379-5386(2015).
RN   [27]
RP   INVOLVEMENT IN COACH1, VARIANT COACH1 ALA-132, AND CHARACTERIZATION OF
RP   VARIANT COACH1 ALA-132.
RX   PubMed=28860541; DOI=10.1038/s41598-017-10652-z;
RA   Lee S.H., Nam T.S., Li W., Kim J.H., Yoon W., Choi Y.D., Kim K.H., Cai H.,
RA   Kim M.J., Kim C., Choy H.E., Kim N., Chay K.O., Kim M.K., Choi S.Y.;
RT   "Functional validation of novel MKS3/TMEM67 mutations in COACH syndrome.";
RL   Sci. Rep. 7:10222-10222(2017).
RN   [28]
RP   VARIANTS RHYNS 208-ARG--ILE-995 DEL AND GLY-430, AND INVOLVEMENT IN RHYNS.
RX   PubMed=29891882; DOI=10.1038/s41431-018-0183-6;
RG   Undiagnosed Disease Network Italy;
RA   Brancati F., Camerota L., Colao E., Vega-Warner V., Zhao X., Zhang R.,
RA   Bottillo I., Castori M., Caglioti A., Sangiuolo F., Novelli G.,
RA   Perrotti N., Otto E.A.;
RT   "Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome.";
RL   Eur. J. Hum. Genet. 26:1266-1271(2018).
RN   [29]
RP   VARIANT MKS3 ALA-786.
RX   PubMed=31411728; DOI=10.1111/cge.13623;
RA   Radhakrishnan P., Nayak S.S., Shukla A., Lindstrand A., Girisha K.M.;
RT   "Meckel syndrome: Clinical and mutation profile in six fetuses.";
RL   Clin. Genet. 96:560-565(2019).
RN   [30]
RP   VARIANT JBTS6 SER-242.
RX   PubMed=32000717; DOI=10.1186/s12881-020-0962-0;
RA   Bui T.P.H., Nguyen N.T., Ngo V.D., Nguyen H.N., Ly T.T.H., Do H.D.,
RA   Huynh M.T.;
RT   "Novel compound heterozygous TMEM67 variants in a Vietnamese family with
RT   Joubert syndrome: a case report.";
RL   BMC Med. Genet. 21:18-18(2020).
RN   [31]
RP   CHARACTERIZATION OF VARIANT GLU-359, CHARACTERIZATION OF VARIANT COACH1
RP   ARG-782, CHARACTERIZATION OF VARIANTS MKS3 PRO-376 AND GLU-786, AND
RP   MUTAGENESIS OF CYS-170; THR-176; HIS-790 AND GLY-979.
RX   PubMed=34964473; DOI=10.1093/hmg/ddab344;
RA   Lange K.I., Best S., Tsiropoulou S., Berry I., Johnson C.A., Blacque O.E.;
RT   "Interpreting ciliopathy-associated missense variants of uncertain
RT   significance (VUS) in Caenorhabditis elegans.";
RL   Hum. Mol. Genet. 31:1574-1587(2022).
CC   -!- FUNCTION: Required for ciliary structure and function. Part of the
CC       tectonic-like complex which is required for tissue-specific
CC       ciliogenesis and may regulate ciliary membrane composition (By
CC       similarity). Involved in centrosome migration to the apical cell
CC       surface during early ciliogenesis. Involved in the regulation of cilia
CC       length and appropriate number through the control of centrosome
CC       duplication. Is a key regulator of stereociliary bundle orientation (By
CC       similarity). Required for epithelial cell branching morphology.
CC       Essential for endoplasmic reticulum-associated degradation (ERAD) of
CC       surfactant protein C (SFTPC). Involved in the negative regulation of
CC       canonical Wnt signaling, and activation of the non-canonical cascade
CC       stimulated by WNT5A (PubMed:26035863). In non-canonical Wnt signaling,
CC       it may act as ROR2 coreceptor (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BR76, ECO:0000269|PubMed:17185389,
CC       ECO:0000269|PubMed:19515853, ECO:0000269|PubMed:19596800,
CC       ECO:0000269|PubMed:19815549, ECO:0000269|PubMed:26035863}.
CC   -!- SUBUNIT: Homodimer (PubMed:34731008). Part of the tectonic-like complex
CC       (also named B9 complex) (By similarity). Interacts with DNAJB9, DNAJC10
CC       and mutated SFTPC. Interacts with SYNE2 during the early establishment
CC       of cell polarity. Interacts (via C-terminus) with FLNA. Interacts with
CC       TMEM218 (PubMed:35137054). Interacts with WNT5A (PubMed:26035863,
CC       PubMed:34731008). Interacts with ROR2 (PubMed:26035863).
CC       {ECO:0000250|UniProtKB:Q8BR76, ECO:0000269|PubMed:17185389,
CC       ECO:0000269|PubMed:19596800, ECO:0000269|PubMed:19815549,
CC       ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:26035863,
CC       ECO:0000269|PubMed:34731008, ECO:0000269|PubMed:35137054}.
CC   -!- INTERACTION:
CC       Q5HYA8; P05067-2: APP; NbExp=3; IntAct=EBI-11334880, EBI-17264467;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17185389};
CC       Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum
CC       membrane {ECO:0000269|PubMed:19815549}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, cilium {ECO:0000269|PubMed:17185389}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000269|PubMed:22121117}. Note=Localizes at the transition zone, a
CC       region between the basal body and the ciliary axoneme
CC       (PubMed:22121117). {ECO:0000269|PubMed:22121117}.
CC   -!- TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues.
CC       Expressed at higher level in spinal cord. {ECO:0000269|PubMed:16415887,
CC       ECO:0000269|PubMed:17185389}.
CC   -!- DISEASE: Note=TMEM67 mutations result in ciliary dysfunction leading to
CC       a broad spectrum of disorders, collectively termed ciliopathies.
CC       Overlapping clinical features include retinal degeneration, renal
CC       cystic disease, skeletal abnormalities, fibrosis of various organ, and
CC       a complex range of anatomical and functional defects of the central and
CC       peripheral nervous system. The ciliopathy range of diseases includes
CC       Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, and
CC       nephronophtisis among others. Single-locus allelism is insufficient to
CC       explain the variable penetrance and expressivity of such disorders,
CC       leading to the suggestion that variations across multiple sites of the
CC       ciliary proteome influence the clinical outcome.
CC       {ECO:0000269|PubMed:18327255, ECO:0000269|PubMed:21633164}.
CC   -!- DISEASE: Meckel syndrome 3 (MKS3) [MIM:607361]: A disorder
CC       characterized by a combination of renal cysts and variably associated
CC       features including developmental anomalies of the central nervous
CC       system (typically encephalocele), hepatic ductal dysplasia and cysts,
CC       and polydactyly. {ECO:0000269|PubMed:16415887,
CC       ECO:0000269|PubMed:17185389, ECO:0000269|PubMed:17377820,
CC       ECO:0000269|PubMed:19466712, ECO:0000269|PubMed:20232449,
CC       ECO:0000269|PubMed:26035863, ECO:0000269|PubMed:26191240,
CC       ECO:0000269|PubMed:31411728, ECO:0000269|PubMed:34964473}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Joubert syndrome 6 (JBTS6) [MIM:610688]: A disorder presenting
CC       with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal
CC       breathing abnormalities and psychomotor delay. Neuroradiologically, it
CC       is characterized by cerebellar vermian hypoplasia/aplasia, thickened
CC       and reoriented superior cerebellar peduncles, and an abnormally large
CC       interpeduncular fossa, giving the appearance of a molar tooth on
CC       transaxial slices (molar tooth sign). Additional variable features
CC       include retinal dystrophy and renal disease.
CC       {ECO:0000269|PubMed:17160906, ECO:0000269|PubMed:19508969,
CC       ECO:0000269|PubMed:19574260, ECO:0000269|PubMed:21633164,
CC       ECO:0000269|PubMed:26477546, ECO:0000269|PubMed:32000717}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Bardet-Biedl syndrome 14 (BBS14) [MIM:615991]: A syndrome
CC       characterized by usually severe pigmentary retinopathy, early-onset
CC       obesity, polydactyly, hypogenitalism, renal malformation and
CC       intellectual disability. Secondary features include diabetes mellitus,
CC       hypertension and congenital heart disease. Bardet-Biedl syndrome
CC       inheritance is autosomal recessive, but three mutated alleles (two at
CC       one locus, and a third at a second locus) may be required for clinical
CC       manifestation of some forms of the disease.
CC       {ECO:0000269|PubMed:18327255}. Note=The gene represented in this entry
CC       may act as a disease modifier. TMEM67 variations may influence the
CC       expression of Bardet-Biedl syndrome in patients who have causative
CC       mutations in other genes. Heterozygosity for a complex mutation in the
CC       TMEM67 gene coding for a protein with 2 in cis changes, and
CC       homozygosity for a truncating mutation of the CEP290 gene has been
CC       found in a patient with Bardet-Biedl syndrome 14.
CC   -!- DISEASE: COACH syndrome 1 (COACH1) [MIM:216360]: A form of COACH
CC       syndrome, a disorder characterized by cerebellar vermis hypoplasia,
CC       developmental delay, impaired intellectual development, ataxia, and
CC       hepatic fibrosis. Patients present the molar tooth sign, a midbrain-
CC       hindbrain malformation pathognomonic for Joubert syndrome and related
CC       disorders. Other features, such as coloboma and renal cysts, may be
CC       variable. COACH1 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:19058225, ECO:0000269|PubMed:19574260,
CC       ECO:0000269|PubMed:28860541, ECO:0000269|PubMed:34964473}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Nephronophthisis 11 (NPHP11) [MIM:613550]: A disorder
CC       characterized by the association of nephronophthisis with hepatic
CC       fibrosis. Nephronophthisis is a progressive tubulo-interstitial kidney
CC       disorder histologically characterized by modifications of the tubules
CC       with thickening of the basement membrane, interstitial fibrosis and, in
CC       the advanced stages, medullary cysts. Typical clinical features are
CC       chronic renal failure, anemia, polyuria, polydipsia, isosthenuria, and
CC       growth retardation. Associations with extrarenal symptoms, especially
CC       ocular lesions, are frequent. {ECO:0000269|PubMed:19508969}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: RHYNS syndrome (RHYNS) [MIM:602152]: An autosomal recessive
CC       syndrome characterized by gaze palsy, retinitis pigmentosa,
CC       sensorineural hearing loss, hypopituitarism, nephronophthisis, and
CC       skeletal dysplasia. {ECO:0000269|PubMed:29891882}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH32835.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG52507.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAG52959.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=EAW91703.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX648768; CAI45999.1; -; mRNA.
DR   EMBL; AC010834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW91703.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK092244; BAG52507.1; ALT_SEQ; mRNA.
DR   EMBL; AK094935; BAG52959.1; ALT_INIT; mRNA.
DR   EMBL; BC032835; AAH32835.1; ALT_INIT; mRNA.
DR   CCDS; CCDS6258.2; -.
DR   RefSeq; NP_001135773.1; NM_001142301.1.
DR   RefSeq; NP_714915.3; NM_153704.5.
DR   PDB; 7FH1; EM; 3.34 A; A/B=1-995.
DR   PDBsum; 7FH1; -.
DR   AlphaFoldDB; Q5HYA8; -.
DR   EMDB; EMD-31584; -.
DR   SMR; Q5HYA8; -.
DR   BioGRID; 124799; 161.
DR   ComplexPortal; CPX-2531; MKS transition zone complex.
DR   CORUM; Q5HYA8; -.
DR   FunCoup; Q5HYA8; 858.
DR   IntAct; Q5HYA8; 123.
DR   STRING; 9606.ENSP00000389998; -.
DR   TCDB; 9.B.77.1.1; the meckel syndrome protein (meckelin) family.
DR   GlyCosmos; Q5HYA8; 1 site, No reported glycans.
DR   GlyGen; Q5HYA8; 4 sites, 2 N-linked glycans (1 site).
DR   iPTMnet; Q5HYA8; -.
DR   PhosphoSitePlus; Q5HYA8; -.
DR   BioMuta; TMEM67; -.
DR   DMDM; 317373389; -.
DR   jPOST; Q5HYA8; -.
DR   MassIVE; Q5HYA8; -.
DR   PaxDb; 9606-ENSP00000389998; -.
DR   PeptideAtlas; Q5HYA8; -.
DR   ProteomicsDB; 33938; -.
DR   Pumba; Q5HYA8; -.
DR   Antibodypedia; 25725; 87 antibodies from 25 providers.
DR   DNASU; 91147; -.
DR   Ensembl; ENST00000323130.8; ENSP00000314488.4; ENSG00000164953.17.
DR   Ensembl; ENST00000453321.8; ENSP00000389998.3; ENSG00000164953.17.
DR   GeneID; 91147; -.
DR   KEGG; hsa:91147; -.
DR   MANE-Select; ENST00000453321.8; ENSP00000389998.3; NM_153704.6; NP_714915.3.
DR   UCSC; uc003yga.5; human.
DR   AGR; HGNC:28396; -.
DR   ClinPGx; PA142670780; -.
DR   CTD; 91147; -.
DR   DisGeNET; 91147; -.
DR   GeneCards; TMEM67; -.
DR   GeneReviews; TMEM67; -.
DR   HGNC; HGNC:28396; TMEM67.
DR   HPA; ENSG00000164953; Tissue enhanced (heart).
DR   MalaCards; TMEM67; -.
DR   MIM; 216360; phenotype.
DR   MIM; 602152; phenotype.
DR   MIM; 607361; phenotype.
DR   MIM; 609884; gene.
DR   MIM; 610688; phenotype.
DR   MIM; 613550; phenotype.
DR   MIM; 615991; phenotype.
DR   OpenTargets; ENSG00000164953; -.
DR   Orphanet; 475; Isolated Joubert syndrome.
DR   Orphanet; 1454; Joubert syndrome with hepatic defect.
DR   Orphanet; 564; Meckel syndrome.
DR   Orphanet; 140976; RHYNS syndrome.
DR   Orphanet; 84081; Senior-Boichis syndrome.
DR   VEuPathDB; HostDB:ENSG00000164953; -.
DR   eggNOG; KOG4611; Eukaryota.
DR   GeneTree; ENSGT00390000010606; -.
DR   InParanoid; Q5HYA8; -.
DR   OMA; YITENKG; -.
DR   OrthoDB; 419138at2759; -.
DR   PAN-GO; Q5HYA8; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q5HYA8; -.
DR   PathwayCommons; Q5HYA8; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   SignaLink; Q5HYA8; -.
DR   Agora; ENSG00000164953; -.
DR   BioGRID-ORCS; 91147; 5 hits in 1155 CRISPR screens.
DR   ChiTaRS; TMEM67; human.
DR   GeneWiki; TMEM67; -.
DR   GenomeRNAi; 91147; -.
DR   Pharos; Q5HYA8; Tbio.
DR   PRO; PR:Q5HYA8; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q5HYA8; protein.
DR   Bgee; ENSG00000164953; Expressed in buccal mucosa cell and 138 other cell types or tissues.
DR   ExpressionAtlas; Q5HYA8; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0060170; C:ciliary membrane; IDA:UniProtKB.
DR   GO; GO:0035869; C:ciliary transition zone; IDA:WormBase.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0036038; C:MKS complex; ISS:UniProtKB.
DR   GO; GO:0031005; F:filamin binding; IPI:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IPI:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0036503; P:ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0010826; P:negative regulation of centrosome duplication; IMP:UniProtKB.
DR   GO; GO:0035567; P:non-canonical Wnt signaling pathway; IMP:UniProtKB.
DR   DisProt; DP04123; -.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR019170; Meckelin.
DR   PANTHER; PTHR21274; MECKELIN; 1.
DR   PANTHER; PTHR21274:SF2; MECKELIN; 1.
DR   Pfam; PF09773; Meckelin; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Bardet-Biedl syndrome; Cell membrane; Cell projection;
KW   Ciliopathy; Cilium; Cilium biogenesis/degradation; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Deafness; Disease variant; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Intellectual disability;
KW   Joubert syndrome; Meckel syndrome; Membrane; Nephronophthisis; Obesity;
KW   Proteomics identification; Reference proteome; Retinitis pigmentosa;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..36
FT                   /evidence="ECO:0000255"
FT   CHAIN           37..995
FT                   /note="Meckelin"
FT                   /id="PRO_0000225689"
FT   TOPO_DOM        37..519
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        520..548
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        549..558
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        559..590
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        591..603
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        604..631
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        632..670
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        671..701
FT                   /note="Discontinuously helical; Name=4"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        671..679
FT                   /note="Helical; Name=4A"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        680..688
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        689..701
FT                   /note="Helical; Name=4B"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        702..731
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        732..771
FT                   /note="Discontinuously helical; Name=5"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        732..757
FT                   /note="Helical; Name=5A"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        758..762
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        763..771
FT                   /note="Helical; Name=5B"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        772..926
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        927..952
FT                   /note="Discontinuously helical; Name=6"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        927..929
FT                   /note="Helical; Name=6A"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        930..936
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   INTRAMEM        937..952
FT                   /note="Helical; Name=6B"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        953..957
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TRANSMEM        958..985
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   TOPO_DOM        986..995
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   REGION          37..280
FT                   /note="Cysteine-rich"
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   COILED          828..917
FT                   /evidence="ECO:0000269|PubMed:34731008"
FT   CARBOHYD        141
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   CARBOHYD        242
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   CARBOHYD        318
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        49..62
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        65..78
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        80..97
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        100..114
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        117..127
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        129..150
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        153..170
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        173..184
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        186..197
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        237..246
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        253..268
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   DISULFID        357..378
FT                   /evidence="ECO:0000269|PubMed:34731008,
FT                   ECO:0007744|PDB:7FH1"
FT   VARIANT         44..995
FT                   /note="Missing (in JBTS6)"
FT                   /evidence="ECO:0000269|PubMed:19508969"
FT                   /id="VAR_081741"
FT   VARIANT         54
FT                   /note="Y -> C (in MKS3; uncertain significance;
FT                   dbSNP:rs386834188)"
FT                   /evidence="ECO:0000269|PubMed:19466712"
FT                   /id="VAR_062310"
FT   VARIANT         82
FT                   /note="P -> R (in JBTS6; uncertain significance;
FT                   dbSNP:rs772437766)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063783"
FT   VARIANT         82
FT                   /note="P -> S (in JBTS6; uncertain significance;
FT                   dbSNP:rs762543032)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063784"
FT   VARIANT         90
FT                   /note="N -> K (found in Joubert syndrome-related disorder;
FT                   likely pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076871"
FT   VARIANT         99
FT                   /note="K -> N (in COACH1; uncertain significance;
FT                   dbSNP:rs797046045)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063785"
FT   VARIANT         124
FT                   /note="E -> K (found in Joubert syndrome-related disorder;
FT                   likely pathogenic; dbSNP:rs375824494)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076872"
FT   VARIANT         130
FT                   /note="P -> R (in COACH1; dbSNP:rs863225226)"
FT                   /evidence="ECO:0000269|PubMed:19058225,
FT                   ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063786"
FT   VARIANT         132
FT                   /note="G -> A (in COACH1; does not affect protein
FT                   abundance; fails to rescue the hydrocephalus phenotype in a
FT                   zebrafish model; dbSNP:rs1490496033)"
FT                   /evidence="ECO:0000269|PubMed:28860541"
FT                   /id="VAR_079632"
FT   VARIANT         172
FT                   /note="R -> Q (in COACH1; uncertain significance;
FT                   dbSNP:rs750950408)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063787"
FT   VARIANT         208..995
FT                   /note="Missing (in JBTS6, MKS3 and RHYNS)"
FT                   /evidence="ECO:0000269|PubMed:17377820,
FT                   ECO:0000269|PubMed:19508969, ECO:0000269|PubMed:29891882"
FT                   /id="VAR_081742"
FT   VARIANT         218
FT                   /note="G -> A (in dbSNP:rs202036490)"
FT                   /evidence="ECO:0000269|PubMed:18327255"
FT                   /id="VAR_062311"
FT   VARIANT         242
FT                   /note="N -> S (in COACH1 and JBTS6)"
FT                   /evidence="ECO:0000269|PubMed:19574260,
FT                   ECO:0000269|PubMed:32000717"
FT                   /id="VAR_063788"
FT   VARIANT         245
FT                   /note="S -> F (in MKS3; uncertain significance;
FT                   dbSNP:rs386834206)"
FT                   /evidence="ECO:0000269|PubMed:19466712"
FT                   /id="VAR_062312"
FT   VARIANT         252
FT                   /note="M -> T (in MKS3, JBTS6 and COACH1; loss of
FT                   interaction with WNT5A; dbSNP:rs202149403)"
FT                   /evidence="ECO:0000269|PubMed:17377820,
FT                   ECO:0000269|PubMed:19466712, ECO:0000269|PubMed:19508969,
FT                   ECO:0000269|PubMed:19574260, ECO:0000269|PubMed:26035863"
FT                   /id="VAR_062313"
FT   VARIANT         257
FT                   /note="M -> V (in COACH1; uncertain significance;
FT                   dbSNP:rs863225227)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063789"
FT   VARIANT         261
FT                   /note="D -> N (in dbSNP:rs35793208)"
FT                   /evidence="ECO:0000269|PubMed:18327255"
FT                   /id="VAR_062314"
FT   VARIANT         290
FT                   /note="W -> L (in NPHP11; dbSNP:rs267607117)"
FT                   /evidence="ECO:0000269|PubMed:19508969"
FT                   /id="VAR_064185"
FT   VARIANT         296
FT                   /note="W -> C (in MKS3; uncertain significance;
FT                   dbSNP:rs386834208)"
FT                   /evidence="ECO:0000269|PubMed:19466712"
FT                   /id="VAR_062315"
FT   VARIANT         301
FT                   /note="D -> E (found in Joubert syndrome-related disorder;
FT                   likely pathogenic; dbSNP:rs756906837)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076873"
FT   VARIANT         320
FT                   /note="S -> C (is a modifier of Bardet-Biedl syndrome;
FT                   found in a BBS14 patient also carrying a homozygous
FT                   truncating mutation of the CEP290 gene; dbSNP:rs111619594)"
FT                   /evidence="ECO:0000269|PubMed:18327255"
FT                   /id="VAR_062316"
FT   VARIANT         349
FT                   /note="L -> S (in COACH1 and MKS3; loss of interaction with
FT                   WNT5A; dbSNP:rs386834180)"
FT                   /evidence="ECO:0000269|PubMed:19574260,
FT                   ECO:0000269|PubMed:20232449, ECO:0000269|PubMed:26035863"
FT                   /id="VAR_063790"
FT   VARIANT         358
FT                   /note="P -> L (in COACH1 and JBTS6; found in a patient with
FT                   Joubert syndrome that also carries mutation 1329-R--S-1332
FT                   Del in KIF7; dbSNP:rs863225232)"
FT                   /evidence="ECO:0000269|PubMed:19574260,
FT                   ECO:0000269|PubMed:21633164"
FT                   /id="VAR_063791"
FT   VARIANT         359
FT                   /note="D -> E (does not affect Wnt signaling regulation;
FT                   when expressed in TMEM67-null cells it induces ROR2
FT                   phosphorylation upon stimulation by WNT5A)"
FT                   /evidence="ECO:0000269|PubMed:34964473"
FT                   /id="VAR_087308"
FT   VARIANT         372
FT                   /note="T -> K (in COACH1; dbSNP:rs863225235)"
FT                   /evidence="ECO:0000269|PubMed:19058225,
FT                   ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063792"
FT   VARIANT         376
FT                   /note="Q -> E (in COACH1; dbSNP:rs863225231)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063793"
FT   VARIANT         376
FT                   /note="Q -> P (in MKS3; leads to endoplasmic reticulum
FT                   retention and prevents localization at the cell membrane;
FT                   decreased function in non-canonical Wnt signaling
FT                   activation; when expressed in TMEM67-null cells does not
FT                   induce ROR2 phosphorylation upon stimulation by WNT5A; loss
FT                   of interaction with WNT5A; dbSNP:rs137853106)"
FT                   /evidence="ECO:0000269|PubMed:16415887,
FT                   ECO:0000269|PubMed:17185389, ECO:0000269|PubMed:26035863,
FT                   ECO:0000269|PubMed:34964473"
FT                   /id="VAR_025474"
FT   VARIANT         430
FT                   /note="D -> G (in RHYNS; may result in exon 13 skipping)"
FT                   /evidence="ECO:0000269|PubMed:29891882"
FT                   /id="VAR_081743"
FT   VARIANT         437
FT                   /note="L -> V (in dbSNP:rs35765535)"
FT                   /evidence="ECO:0000269|PubMed:18327255"
FT                   /id="VAR_062317"
FT   VARIANT         440
FT                   /note="R -> Q (in MKS3 and COACH1; loss of interaction with
FT                   WNT5A; affects Wnt signaling regulation; when expressed in
FT                   TMEM67-null cells does not rescue increased canonical Wnt
FT                   signaling; dbSNP:rs386834182)"
FT                   /evidence="ECO:0000269|PubMed:17377820,
FT                   ECO:0000269|PubMed:19058225, ECO:0000269|PubMed:19466712,
FT                   ECO:0000269|PubMed:26035863"
FT                   /id="VAR_062318"
FT   VARIANT         441
FT                   /note="R -> C (in COACH1; uncertain significance;
FT                   dbSNP:rs752362727)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063794"
FT   VARIANT         441
FT                   /note="R -> L (in MKS3; dbSNP:rs386834183)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076874"
FT   VARIANT         451..995
FT                   /note="Missing (in MKS3)"
FT                   /evidence="ECO:0000269|PubMed:17377820"
FT                   /id="VAR_081744"
FT   VARIANT         485
FT                   /note="P -> S (in COACH1; uncertain significance;
FT                   dbSNP:rs863225228)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063795"
FT   VARIANT         513
FT                   /note="Y -> C (in JBTS6, MKS3 and COACH1;
FT                   dbSNP:rs137853107)"
FT                   /evidence="ECO:0000269|PubMed:17160906,
FT                   ECO:0000269|PubMed:19466712, ECO:0000269|PubMed:19574260"
FT                   /id="VAR_031987"
FT   VARIANT         545
FT                   /note="G -> E (in JBTS6; dbSNP:rs267607114)"
FT                   /evidence="ECO:0000269|PubMed:17160906"
FT                   /id="VAR_031988"
FT   VARIANT         549
FT                   /note="R -> C (in MKS3; affects Wnt signaling regulation;
FT                   when expressed in TMEM67-null cells does not rescue
FT                   increased canonical Wnt signaling)"
FT                   /evidence="ECO:0000269|PubMed:26035863,
FT                   ECO:0000269|PubMed:26191240"
FT                   /id="VAR_087309"
FT   VARIANT         569
FT                   /note="G -> D (found in Joubert syndrome-related disorder;
FT                   likely pathogenic; dbSNP:rs1017800436)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076875"
FT   VARIANT         590
FT                   /note="F -> S (in COACH1; dbSNP:rs267607115)"
FT                   /evidence="ECO:0000269|PubMed:19058225"
FT                   /id="VAR_063796"
FT   VARIANT         604
FT                   /note="I -> V (in dbSNP:rs3134031)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_025475"
FT   VARIANT         615
FT                   /note="C -> R (in MKS3, COACH1 and NPHP11; affects Wnt
FT                   signaling regulation; when expressed in TMEM67-null cells
FT                   does not rescue increased canonical Wnt signaling;
FT                   dbSNP:rs201893408)"
FT                   /evidence="ECO:0000269|PubMed:19466712,
FT                   ECO:0000269|PubMed:19508969, ECO:0000269|PubMed:19574260,
FT                   ECO:0000269|PubMed:26035863"
FT                   /id="VAR_062319"
FT   VARIANT         616
FT                   /note="A -> V (found in Joubert syndrome-related disorder;
FT                   likely pathogenic; dbSNP:rs757204749)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076876"
FT   VARIANT         637
FT                   /note="F -> L (in COACH1; uncertain significance;
FT                   dbSNP:rs863225225)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063797"
FT   VARIANT         668
FT                   /note="W -> R (in MKS3; dbSNP:rs386834189)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076877"
FT   VARIANT         711
FT                   /note="D -> A (in JBTS6; dbSNP:rs781383498)"
FT                   /evidence="ECO:0000269|PubMed:26477546"
FT                   /id="VAR_075699"
FT   VARIANT         728
FT                   /note="S -> G (in COACH1)"
FT                   /evidence="ECO:0000269|PubMed:19058225"
FT                   /id="VAR_063798"
FT   VARIANT         739
FT                   /note="L -> R (found in Joubert syndrome-related disorder;
FT                   likely pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076878"
FT   VARIANT         782
FT                   /note="H -> R (in COACH1; decreased function in
FT                   non-canonical Wnt signaling activation; when expressed in
FT                   TMEM67-null cells does not induce ROR2 phosphorylation upon
FT                   stimulation by WNT5A; dbSNP:rs777137476)"
FT                   /evidence="ECO:0000269|PubMed:19058225,
FT                   ECO:0000269|PubMed:34964473"
FT                   /id="VAR_063799"
FT   VARIANT         786
FT                   /note="G -> A (in MKS3)"
FT                   /evidence="ECO:0000269|PubMed:31411728"
FT                   /id="VAR_087310"
FT   VARIANT         786
FT                   /note="G -> E (in MKS3; decreased function in non-canonical
FT                   Wnt signaling activation; when expressed in TMEM67-null
FT                   cells does not induce ROR2 phosphorylation upon stimulation
FT                   by WNT5A; dbSNP:rs386834193)"
FT                   /evidence="ECO:0000269|PubMed:20232449,
FT                   ECO:0000269|PubMed:34964473"
FT                   /id="VAR_076879"
FT   VARIANT         820
FT                   /note="R -> S (in COACH1)"
FT                   /evidence="ECO:0000269|PubMed:19058225"
FT                   /id="VAR_063800"
FT   VARIANT         821
FT                   /note="G -> R (in NPHP11; dbSNP:rs267607116)"
FT                   /evidence="ECO:0000269|PubMed:19508969"
FT                   /id="VAR_064186"
FT   VARIANT         821
FT                   /note="G -> S (in NPHP11; dbSNP:rs267607116)"
FT                   /evidence="ECO:0000269|PubMed:19508969"
FT                   /id="VAR_064187"
FT   VARIANT         833
FT                   /note="I -> T (in COACH1 and JBTS6; found in a patient with
FT                   Joubert syndrome that also carries mutation 1329-R--S-1332
FT                   Del in KIF7; dbSNP:rs267607119)"
FT                   /evidence="ECO:0000269|PubMed:19058225,
FT                   ECO:0000269|PubMed:19508969, ECO:0000269|PubMed:19574260,
FT                   ECO:0000269|PubMed:21633164"
FT                   /id="VAR_063801"
FT   VARIANT         841
FT                   /note="Q -> P (in COACH1; uncertain significance;
FT                   dbSNP:rs863225234)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063802"
FT   VARIANT         843
FT                   /note="Y -> C (in MKS3; dbSNP:rs386834194)"
FT                   /evidence="ECO:0000269|PubMed:20232449"
FT                   /id="VAR_076880"
FT   VARIANT         942
FT                   /note="F -> C (in COACH1; uncertain significance;
FT                   dbSNP:rs863225233)"
FT                   /evidence="ECO:0000269|PubMed:19574260"
FT                   /id="VAR_063803"
FT   VARIANT         966
FT                   /note="L -> P (in MKS3; dbSNP:rs386834199)"
FT                   /evidence="ECO:0000269|PubMed:17377820,
FT                   ECO:0000269|PubMed:19466712"
FT                   /id="VAR_062320"
FT   MUTAGEN         170
FT                   /note="C->Y: Decreased function in non-canonical Wnt
FT                   signaling activation. When expressed in TMEM67-null cells
FT                   does not induce ROR2 phosphorylation upon stimulation by
FT                   WNT5A."
FT                   /evidence="ECO:0000269|PubMed:34964473"
FT   MUTAGEN         176
FT                   /note="T->I: Does not affect function in non-canonical Wnt
FT                   signaling activation. When expressed in TMEM67-null cells
FT                   it induces ROR2 phosphorylation upon stimulation by WNT5A."
FT                   /evidence="ECO:0000269|PubMed:34964473"
FT   MUTAGEN         790
FT                   /note="H->R: Decreased function in non-canonical Wnt
FT                   signaling activation. When expressed in TMEM67-null cells
FT                   does not induce ROR2 phosphorylation upon stimulation by
FT                   WNT5A."
FT                   /evidence="ECO:0000269|PubMed:34964473"
FT   MUTAGEN         979
FT                   /note="G->R: Does not affect function in non-canonical Wnt
FT                   signaling activation. When expressed in TMEM67-null cells
FT                   it induces ROR2 phosphorylation upon stimulation by WNT5A."
FT                   /evidence="ECO:0000269|PubMed:34964473"
FT   CONFLICT        251
FT                   /note="N -> S (in Ref. 4; BAG52507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        325
FT                   /note="N -> D (in Ref. 4; BAG52507)"
FT                   /evidence="ECO:0000305"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           46..48
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          57..59
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          61..64
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          67..71
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          73..80
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          84..88
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          91..93
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          96..99
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          133..135
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          140..142
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          165..171
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           175..180
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          181..184
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          190..193
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          216..218
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           224..229
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           231..238
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           243..255
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           267..277
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          292..294
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           307..310
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          321..324
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          332..337
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   TURN            350..352
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           361..365
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          375..377
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           382..388
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          394..402
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          408..412
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          421..426
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          428..431
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          444..446
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          459..461
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          463..467
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          470..474
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          491..493
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          498..502
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          508..514
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           519..548
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           558..591
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           603..632
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          635..641
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           667..679
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           688..700
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           704..708
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          709..712
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   TURN            729..731
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           732..757
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           762..771
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   TURN            772..774
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          776..786
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          831..834
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           837..844
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           869..885
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          896..898
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           903..906
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          914..916
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   STRAND          919..921
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   TURN            923..925
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           926..929
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   TURN            930..932
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           936..945
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           947..953
FT                   /evidence="ECO:0007829|PDB:7FH1"
FT   HELIX           958..986
FT                   /evidence="ECO:0007829|PDB:7FH1"
SQ   SEQUENCE   995 AA;  111745 MW;  48B715BDD610C495 CRC64;
     MATRGGAGVA MAVWSLLSAR AVTAFLLLFL PRFLQAQTFS FPFQQPEKCD NNQYFDISAL
     SCVPCGANQR QDARGTSCVC LPGFQMISNN GGPAIICKKC PENMKGVTED GWNCISCPSD
     LTAEGKCHCP IGHILVERDI NGTLLSQATC ELCDGNENSF MVVNALGDRC VRCEPTFVNT
     SRSCACSEPN ILTGGLCFSS TGNFPLRRIS AARYGEVGMS LTSEWFAKYL QSSAAACWVY
     ANLTSCQALG NMCVMNMNSY DFATFDACGL FQFIFENTAG LSTVHSISFW RQNLPWLFYG
     DQLGLAPQVL SSTSLPTNFS FKGENQNTKL KFVAASYDIR GNFLKWQTLE GGVLQLCPDT
     ETRLNAAYSF GTTYQQNCEI PISKILIDFP TPIFYDVYLE YTDENQHQYI LAVPVLNLNL
     QHNKIFVNQD SNSGKWLLTR RIFLVDAVSG RENDLGTQPR VIRVATQISL SVHLVPNTIN
     GNIYPPLITI AYSDIDIKDA NSQSVKVSFS VTYEMDHGEA HVQTDIALGV LGGLAVLASL
     LKTAGWKRRI GSPMIDLQTV VKFLVYYAGD LANVFFIITV GTGLYWLIFF KAQKSVSVLL
     PMPIQEERFV TYVGCAFALK ALQFLHKLIS QITIDVFFID WERPKGKVLK AVEGEGGVRS
     ATVPVSIWRT YFVANEWNEI QTVRKINSLF QVLTVLFFLE VVGFKNLALM DSSSSLSRNP
     PSYIAPYSCI LRYAVSAALW LAIGIIQVVF FAVFYERFIE DKIRQFVDLC SMSNISVFLL
     SHKCFGYYIH GRSVHGHADT NMEEMNMNLK REAENLCSQR GLVPNTDGQT FEIAISNQMR
     QHYDRIHETL IRKNGPARLL SSSASTFEQS IKAYHMMNKF LGSFIDHVHK EMDYFIKDKL
     LLERILGMEF MEPMEKSIFY NDEGYSFSSV LYYGNEATLL IFDLLFFCVV DLACQNFILA
     SFLTYLQQEI FRYIRNTVGQ KNLASKTLVD QRFLI
//
